11 Jefferies Group Evolent Health Trades
Jefferies Group acquired 480k Evolent Health shares worth $4.55M. That's 0.08% of their equity portfolio (204th largest holding). The first Evolent Health trade was made in Q4 2022. Since then Jefferies Group bought shares five more times and sold shares on five occasions. The investor's estimated purchase price is $8.68M, resulting in a loss of 48%.
Avg closing price
Price range
Increased shares by 45.1% (+149k shares)
Q2 2025
Avg closing price
$9.14
Price range
$7.21
-
$11.26
Increased shares by 29.7% (+75.8k shares)
Q1 2025
Avg closing price
$10.14
Price range
$8.55
-
$12.60
Increased shares by 276.0% (+187k shares)
Q4 2024
Avg closing price
$17.33
Price range
$10.87
-
$27.13
Sold 61.6% shares (-109k shares)
Q3 2024
Avg closing price
$25.78
Price range
$18.41
-
$32.97
Increased shares by 16313.8% (+176k shares)
Q2 2024
Avg closing price
$25.54
Price range
$19.12
-
$31.93
Sold 89.0% shares (-8.67k shares)
Q1 2024
Avg closing price
$31.91
Price range
$29.41
-
$34.72
Sold 69.7% shares (-22.5k shares)
Q4 2023
Avg closing price
$28.30
Price range
$23.63
-
$33.52
Sold 46.6% shares (-28.1k shares)
Q3 2023
Avg closing price
$27.80
Price range
$25.00
-
$31.40
Increased shares by 66.2% (+24k shares)
Q2 2023
Avg closing price
$32.33
Price range
$28.05
-
$36.44
Sold 11.2% shares (-4.59k shares)
Q1 2023
Avg closing price
$31.62
Price range
$26.35
-
$35.80
New holding (+40.9k shares)
Q4 2022
Avg closing price
$28.67
Price range
$21.96
-
$37.41
News about Evolent Health Inc - Ordinary Shares - Class A and Jefferies Group
Evolent Health, IBD Stock Of The Day, Breaks Out Amid Fed Uncertainty
Evolent Health Evolent Health EVH $ 33.40 $1.24 3.9% 218% IBD Stock Analysis EVH formed two cup with handle bases ¡ª with buy points at 32.55 and 33.24. Compo...